Disease modifying biomaterials for modulating mechanical allodynia in a preclinical model of rheumatoid arthritis

By afschroeder • November 18, 2025

Dolmat M, Lemes JBP, Johnson WT, Wilkinson EL, Yaksh TL, Bottini N, Shah NJ. Disease modifying biomaterials for modulating mechanical allodynia in a preclinical model of rheumatoid arthritis. Bioeng Transl Med. 2025 Jul 31;10(6):e70054. doi: 10.1002/btm2.70054. PMID: 41244342; PMCID: PMC12617560.

Tags: autoimmunity, biomaterials, Cedars Sinai DoM, pain, Publications, Rheumatology

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial

McDonald CM, Villa C, Soslow JH, Maharry K, Hogan N, Binks M, Berth KC, Elliott KA, Taylor M, Hor KN, Signorovich J, Henricson EK, Phan[...]

Hidden risk in normal myocardial perfusion scans: AI-detected proximal coronary calcium on CT attenuation maps improves prognosis

Zhou J, Miller RJH, Shanbhag A, Killekar A, Han D, Patel KK, Pieszko K, Yi J, Urs MK, Ramirez G, Lemley M, Kavanagh PB, Liang[...]

Correction to: Consensus and Controversies about Diagnosing GH deficiency – A Delphi Survey by the GH Research Society

Radovick S, Arlien-Søborg MC, Boguszewski MCS, Bidlingmaier M, Johannsson G, Grimberg A, Ho KKY, Biller BMK, Choong CS, Hoffman AR, Backeljauw P, Boguszewski CL, Bollerslev[...]